Center-Authored Papers

Filters: Author is Bhatia, Shailender  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
Bhatia S, Tykodi SS, Thompson JA.  2009.  Treatment of metastatic melanoma: an overview.. Oncology (Williston Park, N.Y.). 23(6):488-96. Abstract
2011
Bhatia S, Afanasiev O, Nghiem P.  2011.  Immunobiology of merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.. Current oncology reports. 13(6):488-97. Abstract
2012
Brahmer JR, Tykodi SS, Chow LQM, Hwu W-J, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K et al..  2012.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.. The New England journal of medicine. 366(26):2455-65. Abstract
Bhatia S, Thompson JA.  2012.  Systemic therapy for metastatic melanoma in 2012: dawn of a new era.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(3):403-12. Abstract
Bhatia S, Moon J, Margolin KA, Weber JS, Lao CD, Othus M, Aparicio AM, Ribas A, Sondak VK.  2012.  Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.. PloS one. 7(11):e48787. Abstract
Chapuis AG, Thompson JA, Margolin KA, Rodmyre R, Lai IP, Dowdy K, Farrar EA, Bhatia S, Sabath DE, Cao J et al..  2012.  Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.. Proceedings of the National Academy of Sciences of the United States of America. 109(12):4592-7. Abstract
2013
Miller NJ, Bhatia S, Parvathaneni U, Iyer JG, Nghiem P.  2013.  Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma.. Current treatment options in oncology. 14(2):249-63. Abstract
Blom A, Bhatia S, Pietromonaco S, Koehler K, Iyer JG, Nagase K, Paulson K, Sabath DE, Nghiem P.  2014.  Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.. Journal of the American Academy of Dermatology. 70(3):449-55. Abstract
2014
Blom A, Bhatia S, Pietromonaco S, Koehler K, Iyer JG, Nagase K, Paulson K, Sabath DE, Nghiem P.  2014.  Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.. Journal of the American Academy of Dermatology. 70(3):449-55. Abstract
Bhatia S, Thompson JA.  2014.  Melanoma: immune checkpoint blockade story gets better.. Lancet.
Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT et al..  2014.  Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.. Cancer immunology research. 2(11):1071-9. Abstract
Bhatia S, Curti B, Ernstoff MS, Gordon M, Heath EI, Miller WH, Puzanov I, Quinn DI, Flaig TW, VanVeldhuizen P et al..  2014.  Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study.. Journal for immunotherapy of cancer. 2:2. Abstract
Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran ND, Bhrany AD, Hawes SE, Ladra M.  2014.  Fast neutron radiotherapy for primary mucosal melanomas of the head and neck.. Head & neck. 36(8):1162-7. Abstract
Chapuis AG, Afanasiev OK, Iyer JG, Paulson KG, Parvathaneni U, Hwang JH, Lai I, Roberts IM, Sloan HL, Bhatia S et al..  2014.  Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.. Cancer immunology research. 2(1):27-36. Abstract
Garcia JA, Hudes GR, Choueiri TK, Stadler WM, Wood LS, Gurtler J, Bhatia S, Joshi A, Hozak RR, Xu Y et al..  2014.  A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.. Cancer. 120(11):1647-55. Abstract
Adoptive Transfer
Bhatia S, Tykodi SS, Thompson JA.  2009.  Treatment of metastatic melanoma: an overview.. Oncology (Williston Park, N.Y.). 23(6):488-96. Abstract
Antibodies, Monoclonal
Bhatia S, Tykodi SS, Lee SM, Thompson JA.  2015.  Systemic therapy of metastatic melanoma: on the road to cure.. Oncology (Williston Park, N.Y.). 29(2):126-35. Abstract
Bhatia S, Tykodi SS, Thompson JA.  2009.  Treatment of metastatic melanoma: an overview.. Oncology (Williston Park, N.Y.). 23(6):488-96. Abstract
Antibodies, Monoclonal, Humanized
Bhatia S, Tykodi SS, Lee SM, Thompson JA.  2015.  Systemic therapy of metastatic melanoma: on the road to cure.. Oncology (Williston Park, N.Y.). 29(2):126-35. Abstract
Antigens, CD
Bhatia S, Tykodi SS, Thompson JA.  2009.  Treatment of metastatic melanoma: an overview.. Oncology (Williston Park, N.Y.). 23(6):488-96. Abstract
Antineoplastic Agents
Bhatia S, Tykodi SS, Thompson JA.  2009.  Treatment of metastatic melanoma: an overview.. Oncology (Williston Park, N.Y.). 23(6):488-96. Abstract
Bhatia S, Tykodi SS, Lee SM, Thompson JA.  2015.  Systemic therapy of metastatic melanoma: on the road to cure.. Oncology (Williston Park, N.Y.). 29(2):126-35. Abstract
Antineoplastic Combined Chemotherapy Protocols
Bhatia S, Tykodi SS, Thompson JA.  2009.  Treatment of metastatic melanoma: an overview.. Oncology (Williston Park, N.Y.). 23(6):488-96. Abstract
August 2013
Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran ND, Bhrany AD, Hawes SE, Ladra M.  2014.  Fast neutron radiotherapy for primary mucosal melanomas of the head and neck.. Head & neck. 36(8):1162-7. Abstract
August 2014
Bhatia S, Thompson JA.  2014.  Melanoma: immune checkpoint blockade story gets better.. Lancet.